MTOR and hepatocellular carcinoma: Further research reveals that glycochenodeoxycholate (GCDA) may enhance HCC cell proliferation, metabolic activity, and resistance by upregulating S1PR2 receptor expression and activating the PI3K/AKT/mTOR pathway (30).